WHO ICTRP trial

Evaluation of the safety and efficacy of topical CICAPLAST BAUME B5+ in the…

ChiCTR2500101106 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting

Key facts

Trial ID ChiCTR2500101106
Public title Evaluation of the safety and efficacy of topical CICAPLAST BAUME B5+ in the treatment of hand foot syndrome/hand foot skin reaction related to oncotherapy in cancer patients, a single center, open label, controlled clinical study
Scientific title Evaluation of the safety and efficacy of topical CICAPLAST BAUME B5+ in the treatment of hand foot syndrome/hand foot skin reaction related to oncotherapy in cancer patients, a single center, open label, controlled clinical study
Primary sponsor Rui Jin Hospital, School of Medicine, Shanghai Jiao Tong University
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Recruiting
Study type Interventional study
Countries China
Conditions Hand-foot syndrome/Hand-foot skin reaction
Interventions Intervention group:Hands and feet: treat with CICAPLAST BAUME B5 twice a day;Control group:Treat with Urea Ointment twice a day
Registration date Apr 21, 2025
Target size Intervention group:60;Control group:30
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations